AELIX Therapeutics

📍 Barcelona, Spain👥 1 employees💰 Last funded 2021
Biotechnology Research🌐 aelixtherapeutics.com
Website LinkedIn
AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen.
5
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Spain
3
Ireland
1
Belgium
1
Investor activity2015–2021 · investors recorded per year
20152201612019120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in AELIX Therapeutics?
AELIX Therapeutics has 5 investors on record on gritt.io.
When did AELIX Therapeutics last raise funding?
The most recent investment in AELIX Therapeutics recorded on gritt.io was in 2021.
What industry is AELIX Therapeutics in?
AELIX Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is AELIX Therapeutics based?
AELIX Therapeutics is headquartered in Barcelona, Spain.